[HTML][HTML] Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action

…, L Yue, JC Lo, EG Burchard, CM Brett… - The Journal of …, 2007 - Am Soc Clin Investig
Metformin is among the most widely prescribed drugs for the treatment of type 2 diabetes.
Organic cation transporter 1 (OCT1) plays a role in the hepatic uptake of metformin, but its role …

Outcomes for extremely premature infants

HC Glass, AT Costarino, SA Stayer, CM Brett… - Anesthesia & …, 2015 - journals.lww.com
Premature birth is a significant cause of infant and child morbidity and mortality. In the United
States, the premature birth rate, which had steadily increased during the 1990s and early …

The pharmacogenetics research network: from SNP discovery to clinical drug response

KM Giacomini, CM Brett, RB Altman… - Clinical …, 2007 - Wiley Online Library
The NIH Pharmacogenetics Research Network (PGRN) is a collaborative group of investigators
with a wide range of research interests, but all attempting to correlate drug response with …

Effect of genetic variation in the organic cation transporter 2 on the renal elimination of metformin

…, SW Yee, JH Choi, Y Huang, CM Brett… - Pharmacogenetics …, 2009 - journals.lww.com
Objective The goal of this study was to determine the effect of a genetic variant in the organic
cation transporter 2 (OCT2), OCT2-808G/T, which results in an amino acid change, A270S, …

The effect of novel promoter variants in MATE1 and MATE2 on the pharmacokinetics and pharmacodynamics of metformin

…, CA McCarty, RL Davis, CM Brett… - Clinical …, 2013 - Wiley Online Library
Interindividual variation in response to metformin, first‐line therapy for type 2 diabetes, is
substantial. Given that transporters are determinants of metformin pharmacokinetics, we …

Interaction of methotrexate with organic-anion transporting polypeptide 1A2 and its genetic variants

…, CM Brett, CC Huang, D Stryke, M Kawamoto… - … of Pharmacology and …, 2006 - ASPET
Methotrexate (MTX) is used in patients with malignant and autoimmune diseases. This drug
is primarily excreted unchanged in the urine, and its net excretion occurs via active secretory …

Role of organic cation transporters in drug absorption and elimination

L Zhang, CM Brett, KM Giacomini - Annual Review of …, 1998 - annualreviews.org
▪ Abstract Organic cation transporters are critical in drug absorption, targeting, and disposition.
It has become increasingly clear that multiple mechanisms are involved in organic cation …

CT diagnosis of unsuspected pneumothorax after blunt abdominal trauma

…, MP Federle, RB Jeffrey, CM Brett - American journal of …, 1983 - Am Roentgen Ray Soc
Review of abdominal CT scans for evaluation of blunt abdominal trauma yielded 35 cases
of pneumothorax, 10 of which had not been diagnosed before CT by clinical examination or …

Pre-induction of anesthesia in pediatric patients with nasally administered sufentanil

…, DA Brodsky, DM Fisher, CM Brett… - Survey of …, 1988 - journals.lww.com
Pre-Induction of Anesthesia in Pediatric Patients with Nasal... : Survey of Anesthesiology Pre-Induction
of Anesthesia in Pediatric Patients with Nasally Administered Sufentanil : Survey of …

The human organic anion transporter 3 (OAT3; SLC22A8): genetic variation and functional genomics

…, EJ Carlson, TE Ferrin, CM Brett… - American Journal …, 2006 - journals.physiology.org
The human organic anion transporter, OAT3 (SLC22A8), plays a critical role in renal drug
elimination, by mediating the entry of a wide variety of organic anions, including a number of …